Japan Tobacco Inc
TSE:2914
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
3 454
4 571
|
Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one Japan Tobacco Inc stock under the Base Case scenario is 6 223.88 JPY. Compared to the current market price of 4 236 JPY, Japan Tobacco Inc is Undervalued by 32%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Japan Tobacco Inc
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for Japan Tobacco Inc cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Japan Tobacco Inc. (JT) is a prominent player in the global tobacco industry, rooted in its origins as a state-owned monopoly that began the journey in 1949. Over the decades, Japan Tobacco has transformed into a formidable multinational corporation, operating in over 70 countries and managing a diverse portfolio of well-known brands. Its flagship products, including Winston, Camel, and Mevius, form a significant part of its revenue stream, appealing to a wide range of adult consumers. In recent years, JT has strategically shifted its focus towards reduced-risk products, such as heated tobacco and vaping devices, in response to changing consumer preferences and increasing regulatory scrutiny...
Japan Tobacco Inc. (JT) is a prominent player in the global tobacco industry, rooted in its origins as a state-owned monopoly that began the journey in 1949. Over the decades, Japan Tobacco has transformed into a formidable multinational corporation, operating in over 70 countries and managing a diverse portfolio of well-known brands. Its flagship products, including Winston, Camel, and Mevius, form a significant part of its revenue stream, appealing to a wide range of adult consumers. In recent years, JT has strategically shifted its focus towards reduced-risk products, such as heated tobacco and vaping devices, in response to changing consumer preferences and increasing regulatory scrutiny. This evolution demonstrates the company’s resilience and adaptability, designed to capture value in an ever-evolving market landscape.
For investors, Japan Tobacco presents a compelling opportunity characterized by steady dividend returns and a strong commitment to shareholder value. As a company with a solid balance sheet and robust cash flow, JT is well-positioned to navigate the challenges inherent in the tobacco sector. With ongoing investments in innovative products and a strategic pivot towards less harmful alternatives, the company aims to sustain its competitive edge while addressing public health concerns. Furthermore, its global footprint and market penetration provide diverse revenue streams, mitigating risks tied to regional regulations. Consequently, for those seeking a blend of stability and growth potential in their investment portfolio, Japan Tobacco Inc. offers a noteworthy consideration aligned with evolving industry trends.
Japan Tobacco Inc. (JT) operates in several core business segments that contribute to its overall revenue and market presence. Here are the primary segments:
-
Tobacco Products: This is the largest segment and includes the manufacture and sale of cigarettes and other tobacco products. JT's well-known brands include Mild Seven (now known as Mevius), Winston, and Camel. The company is a significant player in both the domestic Japanese market and international markets.
-
Pharmaceuticals: JT has a pharmaceutical division that focuses on research and development (R&D) in areas such as oncology and central nervous system disorders. This segment aims to leverage its expertise in R&D to develop innovative treatments and contribute to healthcare advancements.
-
Processed Foods: The company operates a processed foods division that includes the production and sale of a variety of food products. This segment allows JT to diversify its revenue streams beyond traditional tobacco products.
-
Investments and Others: This segment encompasses JT’s investment activities and other non-tobacco related ventures. It includes international investments and partnerships, as well as financial services.
Overall, Japan Tobacco Inc. is strategically focused on consolidating its position in the tobacco market while exploring growth opportunities in pharmaceuticals and processed foods, reflecting a broader trend of diversification in consumer goods companies.
Japan Tobacco Inc. (JT) possesses several unique competitive advantages that differentiate it from its rivals in the global tobacco market. Here are some key aspects:
-
Strong Domestic Market Position: JT is the largest tobacco company in Japan, benefiting from a strong presence in its home market, which provides a stable revenue source and brand loyalty.
-
Diversified Product Portfolio: JT has diversified its product offerings beyond traditional cigarettes. It has invested in reduced-risk products (RRPs) such as heated tobacco and e-cigarettes, adapting to changing consumer preferences and regulatory landscapes.
-
Innovation and R&D Investment: The company invests significantly in research and development, which enables it to stay ahead in product innovation. This focus can lead to the development of new products that align with health concerns and regulatory changes.
-
Established Global Presence: Through acquisitions and partnerships, JT has expanded its footprint in international markets. Its global operations allow for economies of scale, diversified risk, and access to various consumer bases.
-
Regulatory Expertise: With extensive experience in navigating complex regulatory environments in different countries, JT is well-positioned to adapt to changing regulations that could disadvantage less experienced competitors.
-
Vertical Integration: JT controls multiple stages of its supply chain, from production to distribution. This vertical integration can lead to cost advantages and improved efficiency.
-
Brand Equity: JT owns several well-known brands, which sustain customer loyalty and give it pricing power in competitive markets. Strong branding can lead to higher margins compared to lesser-known or emerging brands.
-
Proven Track Record in Emerging Markets: JT has shown capability in entering and establishing itself in emerging markets, which may offer substantial growth opportunities as tobacco consumption increases in those regions.
-
Strategic Partnerships: JT has formed partnerships and collaborations that leverage synergies, whether through sharing technology in RRP development or co-marketing initiatives.
-
Strong Financial Position: A solid balance sheet and cash flow allow JT to invest in growth, R&D, and strategic acquisitions without as much reliance on external financing.
These advantages, combined with a strategic focus on adapting to market changes, position Japan Tobacco Inc. competitively against its rivals in the tobacco industry.
Japan Tobacco Inc. (JT) faces several risks and challenges in the near future, including:
-
Regulatory Pressure: Increasing regulations on tobacco products, including stricter advertising laws, plain packaging requirements, and higher taxes, can impact sales and profit margins.
-
Declining Smoking Rates: A global trend towards reduced smoking due to health awareness campaigns and anti-smoking laws can lead to decreased demand for traditional tobacco products.
-
Emergence of Reduced-Risk Products: The rise of alternatives such as e-cigarettes, vaping products, and heated tobacco products presents both opportunities and challenges. JT will need to invest in and adapt to changing consumer preferences while facing competition from established brands and newer entrants.
-
Market Saturation: In mature markets like Japan, high saturation levels in tobacco consumption can limit growth prospects, making it difficult to capture new customers.
-
Public Health Campaigns: Ongoing public health campaigns against smoking could lead to heightened scrutiny and negative sentiment towards tobacco companies, affecting brand reputation and sales.
-
Economic Factors: Economic downturns can lead to decreased disposable income, potentially affecting sales of tobacco products. Additionally, fluctuations in currency exchange rates can impact profitability, particularly since JT operates internationally.
-
Supply Chain Disruptions: Global supply chain challenges, exacerbated by events like the COVID-19 pandemic, can affect production and distribution capabilities, impacting inventory management and possibly leading to increased costs.
-
Legal Risks: Ongoing litigation related to health claims and marketing practices can pose significant financial risks and impact the company's reputation.
-
Technological Disruption: Rapid technological advances in product development, especially in the electronic and alternative tobacco spaces, may require continuous investment and adaptation to keep up with competitors.
-
Changing Consumer Preferences: The shift towards healthier lifestyles and non-tobacco alternatives necessitates that JT innovate and diversify its product offerings to stay relevant in the marketplace.
To mitigate these risks, Japan Tobacco Inc. will need to adopt a proactive strategy that focuses on innovation, compliance with regulations, and understanding evolving consumer behaviors.
Revenue & Expenses Breakdown
Japan Tobacco Inc
Balance Sheet Decomposition
Japan Tobacco Inc
Current Assets | 3T |
Cash & Short-Term Investments | 895.7B |
Receivables | 566.4B |
Other Current Assets | 1.5T |
Non-Current Assets | 4T |
Long-Term Investments | 211.3B |
PP&E | 830.7B |
Intangibles | 2.8T |
Other Non-Current Assets | 162.1B |
Current Liabilities | 1.6T |
Accounts Payable | 481.9B |
Other Current Liabilities | 1.1T |
Non-Current Liabilities | 1.5T |
Long-Term Debt | 888.9B |
Other Non-Current Liabilities | 588.7B |
Earnings Waterfall
Japan Tobacco Inc
Revenue
|
3.1T
JPY
|
Cost of Revenue
|
-1.4T
JPY
|
Gross Profit
|
1.7T
JPY
|
Operating Expenses
|
-1T
JPY
|
Operating Income
|
667.3B
JPY
|
Other Expenses
|
-184.6B
JPY
|
Net Income
|
482.7B
JPY
|
Free Cash Flow Analysis
Japan Tobacco Inc
JPY | |
Free Cash Flow | JPY |
Japan Tobacco Inc. has revised its financial outlook positively, expecting a core revenue growth of 9% year-on-year, an increase of JPY 97 billion, largely driven by strong pricing strategies and market momentum post-Vector acquisition. The adjusted operating profit (AOP) is similarly forecasted to rise by 9%, up JPY 27 billion, amid stable costs. The tobacco segment experienced a 2.6% AOP growth at constant FX. However, net profit has been revised down by JPY 8 billion due to higher financial costs and taxes. The company aims to maintain its dividend at JPY 194 per share despite changes in profit outlook.
What is Earnings Call?
Profitability Score
Profitability Due Diligence
Japan Tobacco Inc's profitability score is 60/100. The higher the profitability score, the more profitable the company is.
Score
Japan Tobacco Inc's profitability score is 60/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Japan Tobacco Inc's solvency score is 75/100. The higher the solvency score, the more solvent the company is.
Score
Japan Tobacco Inc's solvency score is 75/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Japan Tobacco Inc
According to Wall Street analysts, the average 1-year price target for Japan Tobacco Inc is 4 693.39 JPY with a low forecast of 4 242 JPY and a high forecast of 5 250 JPY.
Dividends
Current shareholder yield for Japan Tobacco Inc is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Japan Tobacco, Inc. engages in the manufacture and sale of tobacco, pharmaceutical and processed food products. The company is headquartered in Minato-Ku, Tokyo-To and currently employs 55,381 full-time employees. The firm operates through four business segments. The Domestic Tobacco segment is engaged in the production and sale of manufactured tobacco in Japan (including domestic duty-free market and China, Hong Kong and Macao markets under the jurisdiction of China Business Division). The International Tobacco segment is engaged in the production and sale of manufactured tobacco overseas. The Medical segment is engaged in the research, development, production and sale of medical drugs. The Food Processing segment is engaged in the manufacture and sale of frozen and ambient temperature processed foods, bakery, seasoning, among others. The firm is also involved in the leasing of real estate.
Contact
IPO
Employees
Officers
The intrinsic value of one Japan Tobacco Inc stock under the Base Case scenario is 6 223.88 JPY.
Compared to the current market price of 4 236 JPY, Japan Tobacco Inc is Undervalued by 32%.